Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain-Reference-Cited by-同舟云学术

Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain

Published:2024-05-21 Issue:7 Volume:13 Page:1937-1953
ISSN:2193-8245
Container-title:Ophthalmology and Therapy
language:en
Short-container-title:Ophthalmol Ther

Author:

Ruiz-Moreno José M.,Gámez Lechuga María,Calvo Pilar,Merino María^ORCID,Martín Lorenzo Teresa,Maravilla-Herrera Paulina,Gil Jiménez Beatriz,Abraldes Maximino J.

Funder

Roche Farma S.A.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40123-024-00959-2.pdf

Reference40 articles.

1. GBD 2019 Blindness and Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):e144–60.

2. Udaondo P, Parravano M, Vujosevic S, Zur D, Chakravarthy U. Update on current and future management for diabetic maculopathy. Ophthalmol Ther. 2022;11(2):489–502.

3. Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, Berg K, Chakravarthy U, Gerendas BS, et al. Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica. 2017;237(4):185–222.

4. Figueira J, Henriques J, Carneiro Â, Marques-Neves C, Flores R, Castro-Sousa JP, et al. Guidelines for the management of center-involving diabetic macular edema: treatment options and patient monitorization. OPTH. 2021;15:3221–30.

5. Bhandari S, Gabrielle PH, Nguyen V, Daien V, Viola F, Bougamha W, et al. Dexamethasone implant for diabetic macular oedema: 1-year treatment outcomes from the fight retinal blindness! Registry Ophthalmol Ther. 2022;11(2):797–810.